ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

9.47
Delayed Data
As of May 22
 +0.03 / +0.32%
Today’s Change
2.31
Today|||52-Week Range
14.40
+86.79%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for ZIOPHARM Oncology Inc have a median target of 15.00, with a high estimate of 21.00 and a low estimate of 14.00. The median estimate represents a +58.39% increase from the last price of 9.47.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Hold stock in ZIOPHARM Oncology Inc. This rating has held steady since May, when it was downgraded from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.19
Sales
$57.6M
Reporting Date
Aug 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 127.05%
 
 
 
 
 
 
Growthannually -170.97%
 
 
 
 
 
 

Sales

Growthquarterly 21,076.47%
 
 
 
 
 
 
Growthannually 4,146.18%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account